ROSSARISpecialty Chemicals
Rossari Biotech Ltd — Profit & Loss Statement
₹378.60
-4.18%
Rossari Biotech Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | 0.42 Cr | 1.17 Cr | 0.25 Cr | 0.32 Cr | — |
| Tax Rate For Calcs | 0.26 | 0.26 | 0.26 | 0.28 | — |
| Normalized EBITDA | 268.47 Cr | 252.93 Cr | 228.47 Cr | 195.87 Cr | — |
| Total Unusual Items | 1.59 Cr | 4.45 Cr | 0.99 Cr | 1.12 Cr | — |
| Total Unusual Items Excluding Goodwill | 1.59 Cr | 4.45 Cr | 0.99 Cr | 1.12 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | 136.38 Cr | 130.69 Cr | 107.26 Cr | 97.67 Cr | — |
| Reconciled Depreciation | 67.07 Cr | 60.39 Cr | 62.93 Cr | 48.05 Cr | — |
| Reconciled Cost Of Revenue | 1.45K Cr | 1.30K Cr | 1.18K Cr | 1.11K Cr | — |
| EBITDA | 270.07 Cr | 257.38 Cr | 229.47 Cr | 196.99 Cr | — |
| EBIT | 203.00 Cr | 196.99 Cr | 166.53 Cr | 148.93 Cr | — |
| Net Interest Income | -16.95 Cr | -17.13 Cr | -19.79 Cr | -8.59 Cr | — |
| Interest Expense | 17.81 Cr | 19.37 Cr | 22.32 Cr | 12.66 Cr | — |
| Interest Income | 0.86 Cr | 2.24 Cr | 2.52 Cr | 4.07 Cr | — |
| Normalized Income | 135.20 Cr | 127.42 Cr | 106.52 Cr | 96.87 Cr | — |
| Net Income From Continuing And Discontinued Operation | 136.38 Cr | 130.69 Cr | 107.26 Cr | 97.67 Cr | — |
| Total Expenses | 1.88K Cr | 1.64K Cr | 1.50K Cr | 1.35K Cr | — |
| Rent Expense Supplemental | 7.75 Cr | 6.70 Cr | 5.32 Cr | 4.67 Cr | — |
| Diluted Average Shares | 5.54 Cr | 5.53 Cr | 5.54 Cr | 5.52 Cr | — |
| Basic Average Shares | 5.53 Cr | 5.52 Cr | 5.51 Cr | 5.48 Cr | — |
| Diluted EPS | 24.63 | 23.62 | 19.38 | 17.70 | — |
| Basic EPS | 24.66 | 23.67 | 19.46 | 17.81 | — |
| Diluted NI Availto Com Stockholders | 136.38 Cr | 130.69 Cr | 107.26 Cr | 97.67 Cr | — |
| Net Income Common Stockholders | 136.38 Cr | 130.69 Cr | 107.26 Cr | 97.67 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 136.38 Cr | 130.69 Cr | 107.26 Cr | 97.67 Cr | — |
| Minority Interests | 0.00 | 0.00 | 0.00 | -0.02 Cr | — |
| Net Income Including Noncontrolling Interests | 136.38 Cr | 130.69 Cr | 107.26 Cr | 97.69 Cr | — |
| Net Income Continuous Operations | 136.38 Cr | 130.69 Cr | 107.26 Cr | 97.69 Cr | — |
| Tax Provision | 48.81 Cr | 46.93 Cr | 36.96 Cr | 38.58 Cr | — |
| Pretax Income | 185.19 Cr | 177.62 Cr | 144.22 Cr | 136.28 Cr | — |
| Other Non Operating Income Expenses | 1.29 Cr | 0.73 Cr | 1.97 Cr | 5.82 Cr | — |
| Special Income Charges | -0.30 Cr | 1.88 Cr | 0.28 Cr | -0.30 Cr | — |
| Other Special Charges | 0.07 Cr | -1.88 Cr | -0.28 Cr | -0.64 Cr | — |
| Write Off | 0.23 Cr | 0.00 | 0.00 | 0.94 Cr | — |
| Net Non Operating Interest Income Expense | -16.95 Cr | -17.13 Cr | -19.79 Cr | -8.59 Cr | — |
| Interest Expense Non Operating | 17.81 Cr | 19.37 Cr | 22.32 Cr | 12.66 Cr | — |
| Interest Income Non Operating | 0.86 Cr | 2.24 Cr | 2.52 Cr | 4.07 Cr | — |
| Operating Income | 187.45 Cr | 182.72 Cr | 151.63 Cr | 130.17 Cr | — |
| Operating Expense | 434.45 Cr | 338.40 Cr | 321.23 Cr | 231.47 Cr | — |
| Other Operating Expenses | 84.65 Cr | 69.36 Cr | 60.19 Cr | 39.53 Cr | — |
| Depreciation And Amortization In Income Statement | 67.07 Cr | 60.39 Cr | 62.93 Cr | 48.05 Cr | — |
| Amortization | 21.11 Cr | 21.15 Cr | 19.47 Cr | 12.23 Cr | — |
| Depreciation Income Statement | 45.97 Cr | 39.24 Cr | 43.46 Cr | 35.83 Cr | — |
| Selling General And Administration | 122.77 Cr | 81.33 Cr | 82.84 Cr | 63.48 Cr | — |
| Selling And Marketing Expense | 94.75 Cr | 64.36 Cr | 67.50 Cr | 48.37 Cr | — |
| General And Administrative Expense | 28.02 Cr | 16.97 Cr | 15.34 Cr | 15.12 Cr | — |
| Rent And Landing Fees | 7.75 Cr | 6.70 Cr | 5.32 Cr | 4.67 Cr | — |
| Gross Profit | 621.90 Cr | 521.12 Cr | 472.86 Cr | 361.64 Cr | — |
| Cost Of Revenue | 1.45K Cr | 1.30K Cr | 1.18K Cr | 1.11K Cr | — |
| Total Revenue | 2.07K Cr | 1.83K Cr | 1.65K Cr | 1.48K Cr | — |
| Operating Revenue | 2.07K Cr | 1.83K Cr | 1.65K Cr | 1.48K Cr | — |
| Restructuring And Mergern Acquisition | — | — | — | 0.00 | -2.30 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Rossari Biotech Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.